Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.
Mentions
1 mention · latest on 30 Apr 2026
| Q1 2026 Investor Letter | - | 30 Apr 2026 (Q1 2026) |